Correction to: Mol Cancer 18, 163 (2019)
https://doi.org/10.1186/s12943-019-1082-3
Following the publication of the original article [1], the author list lacked a co-author’s name: Mark J. Smyth, and his affiliation is QIMR Berghofer Medical Research Institute. The correct author list should be “Jiajie Hou; He Zhang; Jun Liu; Zhenjun Zhao; Jianye Wang; Zhike Lu; Bian Hu; Jiankui Zhou; Zhicong Zhao; Mingxuan Feng; Haiyan Zhang; Bin Shen; Xingxu Huang; Beicheng Sun; Mark J. Smyth; Chuan He; Qiang Xia”. The error has been corrected in the HTML and PDF version of this article.
Reference
Hou J, Zhang H, Liu J, et al. YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma. Mol Cancer. 2019;18:163 https://doi.org/10.1186/s12943-019-1082-3.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Hou, J., Zhang, H., Liu, J. et al. Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma. Mol Cancer 19, 137 (2020). https://doi.org/10.1186/s12943-020-01257-8
Published:
DOI: https://doi.org/10.1186/s12943-020-01257-8